Supporters
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines in Oncology and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.
To learn more, visit www.astrazeneca.com and follow AstraZeneca on Twitter and LinkedIn
Every day, millions of patients and caregivers rely on Baxter’s leading portfolio of critical care, nutrition, renal, hospital and surgical products. For more than 85 years, we’ve been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers that make it happen. With products, technologies and therapies available in more than 100 countries, Baxter’s employees worldwide are now building upon the company’s rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations. Specific to renal, we have partnered with the nephrology community to focus on pioneering care in both hemodialysis (HD) and peritoneal dialysis (PD); and we maintain that pioneering spirit today through new therapies like expanded hemodialysis (HDx) and remote patient management.
To learn more, visit www.baxter.com and follow Baxter on Twitter, LinkedIn and Facebook.
Boehringer Ingelheim is working on breakthrough therapies that improve the lives of humans and animals. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885 and family-owned ever since, Boehringer Ingelheim takes a long-term perspective. Around 52,000 employees serve more than 130 markets in the three business areas, Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing. Learn more at www.boehringer-ingelheim.com
Follow Boehringer Ingelheim on Twitter, Facebook, LinkedIn and Instagram
Diaverum provides life enhancing renal care to patients with Chronic Kidney Disease (CKD), enabling them to live fulfilling lives. Diaverum is a leading global provider in renal care services and the largest independent provider in Europe. Our focus is haemodialysis, but we offer a portfolio of treatments ranging from preventive care, peritoneal dialysis and home care to coordination of patients’ comorbidities and transplantation services.
Care, true care. For life. Life enhancing renal care. For body, mind and soul. With passion and inspiration. Empowering patients, their friends and family. Because everyone deserves a fulfilling life.
Diaverum
Fresenius Medical Care is the world’s leading provider of products and services for individuals with renal diseases. We care for more than 349,000 patients in our global network of more than 4,070 dialysis clinics. Fresenius Medical Care is also the leading provider of dialysis products such as dialysis machines, dialyzers and related disposables. Along with the core business, the company focuses on expanding the range of related medical services in the field of Care Coordination. Creating a future worth living. For patients. Worldwide. Every day. This vision guides us in our efforts to give our patients around the world a better life by offering them high-quality products and outstanding health care.
www.freseniusmedicalcare.com
At Janssen, we’re creating a future where disease is a thing of the past. We’re the Pharmaceutical Companies of Johnson & Johnson, working tirelessly to make that future a reality for patients everywhere by fighting sickness with science, improving access with ingenuity and healing hopelessness with heart. We focus on areas of medicine where we can make the biggest difference: Cardiovascular & Metabolism, Immunology, Infectious Diseases & Vaccines, Neuroscience, Oncology and Pulmonary Hypertension.
Learn more at www.janssen.com.
Follow us at www.twitter.com/JanssenGlobal.
Janssen Research & Development, LLC is part of the Janssen Pharmaceutical Companies of Johnson & Johnson.
Sanofi Genzyme, the specialty care global business unit of Sanofi, focuses on rare diseases, rare blood disorders, multiple sclerosis, oncology, and immunology. We help people with debilitating and complex conditions that are often difficult to diagnose and treat. Our approach is shaped by our experience developing highly specialized treatments and forging close relationships with physician and patient communities. We are dedicated to discovering and advancing new therapies, providing hope to patients and their families around the world.
Learn more at www.sanofigenzyme.com.
Learn more about World Kidney Day supporters
Our supporters are key in achieving the campaign mission of raising awareness of the importance of our kidneys to our overall health and to reduce the frequency and impact of kidney disease and its associated health problems worldwide. We recognize their own initiatives in patient advocacy and care.
Find additional resources and learn more about each official World Kidney Day supporter by clicking on their name:
Additional resources will be made available here soon
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines in Oncology and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.
Every day, millions of patients and caregivers rely on Baxter’s leading portfolio of critical care, nutrition, renal, hospital and surgical products. For more than 85 years, we’ve been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers that make it happen. With products, technologies and therapies available in more than 100 countries, Baxter’s employees worldwide are now building upon the company’s rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations. Specific to renal, we have partnered with the nephrology community to focus on pioneering care in both hemodialysis (HD) and peritoneal dialysis (PD); and we maintain that pioneering spirit today through new therapies like expanded hemodialysis (HDx) and remote patient management.
Boehringer Ingelheim is working on breakthrough therapies that improve the lives of humans and animals. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885 and family-owned ever since, Boehringer Ingelheim takes a long-term perspective. Around 52,000 employees serve more than 130 markets in the three business areas, Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing.
Diaverum provides life enhancing renal care to patients with Chronic Kidney Disease (CKD), enabling them to live fulfilling lives. Diaverum is a leading global provider in renal care services and the largest independent provider in Europe. Our focus is haemodialysis, but we offer a portfolio of treatments ranging from preventive care, peritoneal dialysis and home care to coordination of patients’ comorbidities and transplantation services.
Care, true care. For life. Life enhancing renal care. For body, mind and soul. Withs passion and inspiration. Empowering patients, their friends and family. Because everyone deserves a fulfilling life.
Fresenius Medical Care is the world’s leading provider of products and services for individuals with renal diseases. We care for more than 349,000 patients in our global network of more than 4,070 dialysis clinics. Fresenius Medical Care is also the leading provider of dialysis products such as dialysis machines, dialyzers and related disposables. Along with the core business, the company focuses on expanding the range of related medical services in the field of Care Coordination. Creating a future worth living. For patients. Worldwide. Every day. This vision guides us in our efforts to give our patients around the world a better life by offering them high-quality products and outstanding health care.
At Janssen, we’re creating a future where disease is a thing of the past. We’re the Pharmaceutical Companies of Johnson & Johnson, working tirelessly to make that future a reality for patients everywhere by fighting sickness with science, improving access with ingenuity and healing hopelessness with heart. We focus on areas of medicine where we can make the biggest difference: Cardiovascular & Metabolism, Immunology, Infectious Diseases & Vaccines, Neuroscience, Oncology and Pulmonary Hypertension.
Sanofi Genzyme, the specialty care global business unit of Sanofi, focuses on rare diseases, rare blood disorders, multiple sclerosis, oncology, and immunology. We help people with debilitating and complex conditions that are often difficult to diagnose and treat. Our approach is shaped by our experience developing highly specialized treatments and forging close relationships with physician and patient communities. We are dedicated to discovering and advancing new therapies, providing hope to patients and their families around the world.
How to become a World Kidney Day supporter
World Kidney Day is celebrated every year on the second Thursday of March. The WKD campaign is only possible thanks to the support of our global supporters.
View support brochure
As an official supporter, you will be:
- Officially associated with the WKD campaign as a supporter
- Able to use the WKD campaign logo along with communication materials such as template press releases, boiler plates and regular updates
- Able to participate in various additional partner activities, as proposed by the WKD team, throughout the year
- Be acknowledged as an official supporter of WKD campaign on various platforms, which includes, but are not limited to:
-
- World Kidney Day website
- ISN website
- Social media
- Campaign materials (Printed and online)
- Communications (Printed and online)
- Participation in quarterly calls with central campaign team for updates on campaign and strategy, help build communication and share information
- Able to use digital campaign materials for internal and external use
- Provided opportunities to share own resources, through official campaign channels, which are patient-focused or education/awareness-building, free of branding and products (agnostic), and approved by campaign team
To become a World Kidney Day supporter, please contact:
Charleigh Claire, Business Development Manager
Email: cclaire@theisn.org
World Kidney Day (WKD) is a global awareness campaign aimed at raising awareness about the importance of our kidneys. WKD is a joint initiative of the International Society of Nephrology (ISN) and the International Federation of Kidney Foundations(IFKF) who, together, generate WKD campaign content, educational material and activities. The annual campaign is overseen by the WKD Steering Committee composed of nephrology and transplantation experts who live and work in Africa, Asia, Australia, Europe, South America and North America. Financial support is solicited with the sole purpose of carrying out the campaign’s core activities and achieving campaign objectives. Our supporters provide financial support to carry out our activities, help us disseminate our message and strengthen our efforts, which WKD is very grateful for. However, supporters do not take part in any of the decision making and do not influence any of the content or messages disseminated by WKD.
The resources on this page are third party and content responsibility lies with owners of the material.
